Estes C, Chan HLY, Chien RN, Chuang WL, Fung J, Goh GB, et al
BPC-157 is not listed in FDA's approved drugs database, and the Department of Defense's Operation Supplement Safety (OPSS) cautions consumers about unapproved peptides found in wellness products
Here are some of its competitors that are already FDA approved for weight management: Liraglutide (Saxenda) : This injectable medication is a once-daily GLP-1 receptor agonist approved for chronic weight management in adults with a body mass index (BMI) of 30 or greater (obesity) or 27 or greater (overweight) with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Working with experts ensures steady and safe results
This program suits adults with a BMI of 30 and above, or those with a BMI of 27 facing weight-related medical challenges such as hypertension, type 2 diabetes, or high cholesterol